Dongwei Zhang
Beijing, 100029, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Salidroside and Apigenin attenuate bone resorption in ovariectomized mice and osteoclasts via Sema3A/Nrp1/PlexinA1 pathway.
Journal: The Journal of nutritional biochemistry
Published: January 31, 2026
Salvia miltiorrhiza Bunge promotes osteogenesis and angiogenesis by activating HIF-1α/VEGF and Slit3 pathways.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: September 24, 2025
Harnessing extracellular vesicles as an emerging diagnostic and therapeutic strategy for osteoporosis.
Journal: Biomaterials science
Published: August 21, 2025
Chlorogenic acid and ferulic acid in SMYAD alleviate diabetic cardiomyopathy by inhibiting cardiac lipotoxicity via GCGR/PPARα and GCGR/AMPK pathways.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: January 20, 2025
Sijunzi decoction improves lipid metabolism via regulation of Wnt/β-catenin signaling pathway in diabetic mice and 3T3-L1 cells.
Journal: Journal of ethnopharmacology
Published: September 30, 2024
Semaphorin 3A on Osteoporosis: An Overreview of the Literature.
Journal: Calcified tissue international
Published: August 23, 2024
Cnidii Fructus: A traditional Chinese medicine herb and source of antiosteoporotic drugs.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: September 15, 2023
SiJunZi decoction ameliorates bone quality and redox homeostasis and regulates advanced glycation end products/receptor for advanced glycation end products and WNT/β-catenin signaling pathways in diabetic mice.
Journal: Journal of ethnopharmacology
Published: June 23, 2023
Fuling-Zexie formula attenuates hyperuricemia-induced nephropathy and inhibits JAK2/STAT3 signaling and NLRP3 inflammasome activation in mice.
Journal: Journal of ethnopharmacology
Published: May 28, 2023
Simiao San alleviates hyperuricemia and kidney inflammation by inhibiting NLRP3 inflammasome and JAK2/STAT3 signaling in hyperuricemia mice.
Journal: Journal of ethnopharmacology
Published: March 06, 2023
Apigenin Ameliorates Hyperuricemia and Renal Injury through Regulation of Uric Acid Metabolism and JAK2/STAT3 Signaling Pathway.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: November 09, 2022
Last Updated: 09/26/2026